companydata.dkcompanydata.dk

K/S BI BIOMEDICAL VENTURE IV: Financial statements 2012

CVR: 28301022

Source: annual report 2012, Danish Business Authority

01/01/2012 – 31/12/2012

K/S BI BIOMEDICAL VENTURE IV (CVR 28301022) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 28,878,000 and a net result of DKK 28,878,000. Equity in the 2012 report amounted to DKK 161,270,000. The solvency ratio was 100%.

Gross Profit
DKK 28,878,000
Profit/Loss
DKK 28,878,000
Equity
DKK 161,270,000
Total Assets
DKK 161,270,000

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on K/S BI BIOMEDICAL VENTURE IV

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

About K/S BI BIOMEDICAL VENTURE IV

K/S BI BIOMEDICAL VENTURE IV is a Danish company of the type Kommanditselskab based in København K, founded in 2004. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Ahmet Turan Kayhan. The board consists of Andrea Panzieri (chair), Allan Funk Nissen and Ahmet Turan Kayhan. The company is owned by PENSIONSKASSEN FOR TEKNIKUM- OG DIPLOMINGENIØRER and LÆRERNES PENSION, FORSIKRINGSAKTIESELSKAB. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK 8,000.

Source: annual report 2025, Danish Business Authority